Biotech China 2014
Cardiometabolic Health Congress 2007
Sheraton Boston Hotel
39 Dalton Street
Boston, MA

Schedule of Presentations:

Wednesday, September 26, 2007
14:00:00 Registration
18:30:00 Dinner Symposium | Prandial Insulin and Cardiovascular Risk Dinner Symposium John E Gerich, William T Cefalu, Lawrence Blonde
Thursday, September 27, 2007
06:30:00 Breakfast Symposium | Cardiometabolic Risk Reduction: Novel Strategies for Achieving Lipid and Glycemic Targets Breakfast Symposium Om P Ganda, Zachary T Bloomgarden, David E Cohen
08:00:00 Opening Remarks Jay S Skyler
08:15:00 The Science Behind Insulin Resistance and Its Impact on Cardiometabolic Risk Keynote Presentation C. Ronald Kahn
08:45:00 Pharmacotherapy for the Management of Type 2 Diabetes Martin J Abrahamson
09:15:00 Exercise as an Intervention to Reduce Cardiovascular Risk in Patients with Diabetes Ronald Sigal
09:45:00 Nutritional Interventions to Reduce Cardiometabolic Risk Judith Wylie-Rosett
10:15:00 Morning Break | Exhibit Hall
10:45:00 Type 2 Diabetes: Interdicting Disease Progression Bernard Zinman
11:15:00 Preventing the Progression of Atherosclerosis in Type 2 Diabetes Henry Ginsberg
11:45:00 Diabetes Prevention: Does It Work? Is It Worthwhile? Panel Discussion Richard W Nesto, Lawrence A Leiter, Hertzel Gerstein, Jay S Skyler, C. Ronald Kahn
12:30:00 Lunch Symposia | Cardiometabolic Risk Management: The Role of Insulin Therapy in Achieving Glycemic Control Paresh Dandona, Richard W Nesto, Jack L Leahy
13:20:00 Advances in Hypertension Management:: The Role of Direct Renin Inhibition in Achieving Blood Pressure Control Matthew R Weir, Kenneth Jamerson, Alan H Gradman
14:00:00 Physiologic Mechanisms of Obesity Samuel Klein
14:30:00 Is It Visceral or Ectopic Fat Deposition, or Is It Both? Kitti Falk Petersen
15:00:00 Afternoon Break | Exhibit Hall
15:30:00 Effects of Adipose Tissue-Derived Cytokines on Cardiovascular Function and Structure Gokhan Hotamisligil,
16:00:00 Pharmacotherapy for Obesity Management: Current Practice and Future Directions Louis J Aronne
16:30:00 Bariatric Surgery: Patient Selection, Procedure Options, and Outcomes Matthew M Hutter
17:00:00 Welcome Reception
17:00:00 Closing Remarks Richard W Nesto
18:30:00 Dinner Symposium | Emerging Concepts in Obesity Management: Integrated Neurohormonal Therapy Stephen R Smith, Michael W Schwartz, Henry Ginsberg
Friday, September 28, 2007
06:30:00 Breakfast Symposia | Expert Roundtable: Emerging Concepts in Cardiometabolic Risk Management Daniel J Rader, Steven M Haffner, Thomas Giles, Christie Ballantyne
07:15:00 Cardiometabolic Risk Reduction: The Role of New Generation Beta-Blockade R. Preston Mason, Gary H Gibbons, George Bakris
08:00:00 Opening Remarks Christie Ballantyne
08:15:00 Atherosclerosis in Patients with Cardiometabolic Risk: New Findings Regarding Inflammation and Neovascularization Keynote Presentation Valentin Fuster
08:45:00 Diabetes and Atherosclerosis: Defining the Link and Opportunities for Intervention Jorge Plutzky
09:15:00 Biomarkers and Noninvasive Imaging: Useful, Hopeful, or Hype? Christie Ballantyne
09:45:00 Morning Break | Exhibit Hall
10:15:00 Risk Assessment Models to Predict Multiple Cardiometabolic Risk Factors Peter WF Wilson
10:45:00 Hypertension Management in Patients with Diabetes and Cardiovascular Disease George Bakris
11:15:00 Antithrombotics for Patients with Increased Cardiometabolic Risk: What Do We Use and for How Long? Deepak L Bhatt
11:45:00 Lunch Symposia | The Role of the Endocannabinoid System in the Management of Cardiometabolic Risk Robert H Eckel, Louis J Aronne, Deepak L Bhatt
12:00:00 Cardiometabolic Risk Management in High-Risk Populations: Medical Management and Lifestyle Modification Strategies Scott Urquhart, Nancy Houston Miller, John P Foreyt
12:20:00 Cardiovascular Risk Reduction: Controlling Dyslipidemia in Patients with Type 2 Diabetes Ronald B Goldberg, Henry Ginsberg, Michael Welsh
13:15:00 Dyslipidemia: Controversies and Difficulties in Lipid Management Panel Discussion Daniel J Rader, Ronald B Goldberg, Henry Ginsberg, Robert H Eckel, Christie Ballantyne
14:15:00 Lipid Management in Children with Type 1 or Type 2 Diabetes Lawrence M Dolan
14:45:00 Afternoon Break | Exhibit Hall
15:15:00 Glycemic Control in Children with Type 1 or Type 2 Diabetes Sonia Caprio
15:45:00 Butting Out: Novel Smoking Cessation Strategies to Reduce Cardiometabolic Risk David Gonzales
17:15:00 Closing Remarks Christie Ballantyne
18:00:00 Dinner Symposium | Reducing Residual Cardiovascular Risk by Lowering Triglycerides and Raising HDL-C Frank M Sacks, Jorge Plutzky, Christie Ballantyne
Saturday, September 29, 2007
06:30:00 Breakfast Symposium | Beyond Hypertension Control: The Role of ARBs in the Management of Cardiometabolic Risk Byron Hoogwerf, Thomas Giles, Willa Hsueh
08:00:00 Opening Remarks Robert H Eckel
08:15:00 The Impact of Personalized Medicine on the Management of the Obese Patient with Multiple Cardiometabolic Risk Factors Allen M Spiegel
08:45:00 Early Kidney Disease: The Underappreciated Cardiometabolic Risk Factor Robert D Toto
09:30:00 The Influence of Genetics on Hypertension and Cardiometabolic Risk Management: Current Strategies and Future Directions Richard P Lifton
10:00:00 Morning Break | Exhibit Hall
10:30:00 Appropriate Revascularization in Patients with Diabetes and Cardiovascular Disease Richard W Nesto
12:00:00 Expert Roundtable: Evaluating Clinical Trial Evidence Robert H Eckel, Richard W Nesto, Steven M Haffner, Christie Ballantyne
12:00:00 Lunch Symposium | Establishing the Relationship Between Erectile Dysfunction and Cardiometabolic Risk: Opportunities for Screening and Early Intervention to Improve Patient Care Parker R Ward, Andrew R McCullough
13:00:00 Closing Remarks Robert H Eckel
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.